Search Results 1251-1260 of 10490 for cannabis

  1. Opium (oral route) - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Cetirizine; Citalopram; Clobazam; Clonazepam; Clopidogrel; Codeine; Cyclobenzaprine; Cyproheptadine ...

  2. Ketamine Associated ACC GABA and Glutamate Change and Depression Remission - Mayo Clinic

    Use of methamphetamine, cocaine, or cannabis. Abuse of stimulant(s) within the prior 12 months. Any current substance use disorder (excluding nicotine and ...

  3. Mayo Clinic

    Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.

  4. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... (cannabis). Subjects with any other severe acute or chronic medical or psychiatric condition or laboratory or electrocardiogram (ECG) abnormality that may ...

  5. Publications - Todd A. Kellogg, M.D. - Mayo Clinic

    Cannabis use and bariatric surgery psychology practice: survey and insights. Surg Obes Relat Dis. 2021 Apr; 17 (4):701-710 Epub 2020 Dec 16. View PubMed ...

  6. Impact of Cannabinoids on Sleep Parameters in Patients Undergoing Sleep Studies - Mayo Clinic

    The overarching purpose of this study is to advance our understanding of how cannabinoids interact with sleep physiology, potentially offering insights into ...

  7. Kratom for opioid withdrawal: Does it work? - Mayo Clinic

    But it can cause addiction and withdrawal symptoms of its own. Dec. 30, 2023. If you take pain medicines such as oxycodone ...

  8. Publications - Ryan W. Stidham, M.D. - Mayo Clinic

    Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis. Am J ...

  9. Perampanel (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Ceritinib; Cetirizine; Clobazam; Clomipramine; Clonazepam; Codeine; Conivaptan; Cyclobenzaprine ...

  10. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subject who has concomitant cannabis use either recreational or for medical reasons within 14 days prior to Baseline or any history of clinically ...